Please login to the form below

Not currently logged in
Email:
Password:

BrightGene

This page shows the latest BrightGene news and features for those working in and with pharma, biotech and healthcare.

UPDATED: Gilead drops remdesivir’s orphan drug designation

UPDATED: Gilead drops remdesivir’s orphan drug designation

Chinese pharma company BrightGene also alleged that it had successfully copied remdesivir and had plans to manufacture a generic version of the drug. ... The SSE said that BrightGene had not gained approval from China’s drug regulator to manufacture

Latest news

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Employee engagement
Route 66: can remote working put two-thirds of us back on the road to engaged employment?
Pre-pandemic, 66% of the world’s workforce weren’t engaged in their jobs – Chris Ross examines how the rush to remote working has impacted employee engagement...
Demonstrating the value of HCP self-serve portals
Develop the art of setting KPIs and metrics aligned to your specific objectives, target personas, key educational messages, content, website features and journeys....

Infographics